Utama › Serangan Jantung › New Jersey
Kajian klinikal Serangan Jantung di New Jersey
5 kajian untuk Serangan Jantung sedang mencari peserta di lokasi di New Jersey.
Teks kajian rasmi (Bahasa Inggeris)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Hypertension & Nephrology Association, Eatontown
- New Jersey Kidney Care, Jersey City
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT05485961An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- The Valley Hospital, Ridgewood
- Overlook Medical Center, Summit
Mengambil pesertaFasa 3
Umur 18 hingga 100 · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07517263OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Advanced Heart Care LLC, Bridgewater
- Advanced Heart and Vascular Institute of Hunterdon, Flemington
- Clinical Reseach Philadelphia Pennington, Hamilton
- dan 7 lagi
Mengambil pesertaFasa 3
Umur 50 hingga 105 · Semua jantina · Dikemas kini 21 Ogo 2026 · NCT07136012AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
- Hackensack University Medical Center, Hackensack
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Jun 2026 · NCT06699056Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- Rutgers University, Newark
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Mac 2026 · NCT04774159Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.